文献速递脊柱关节炎

伤害可塑性与神经病理性疼痛成分与接受生物改善病情抗风湿药治疗的放射学中轴型脊柱关节炎患者残留症状的相关性

Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs.
PubMed 文献 · RMD Open · 2024-02-15

该研究纳入78例接受bDMARDs至少3个月的放射学中轴型脊柱关节炎患者,采用WPI和PainDETECT问卷评估伤害可塑性与神经病理性疼痛成分。多变量回归显示WPI和PD与ASDAS、BASDAI独立相关,且与BASDAI≥4定义的残留症状显著相关,在CRP正常患者中亦存在。

要点

  • WPI和PD分别与ASDAS独立相关(b=0.1,95%CI 0.04-0.17;b=0.05,95%CI 0.02-0.08)。
  • WPI和PD分别与BASDAI独立相关(b=0.24,95%CI 0.08-0.39;b=0.17,95%CI 0.1-0.25)。
  • WPI与BASDAI≥4残留症状相关(OR 1.93,95%CI 1.09-4.15),PD亦相关(OR 1.32,95%CI 1.04-1.85)。

核心结论

  • 伤害可塑性和神经病理性疼痛成分似乎与接受bDMARDs治疗的放射学中轴型脊柱关节炎患者的残留症状相关。

研究设计与样本

  • 来自德国脊柱关节炎起始队列的78例放射学中轴型脊柱关节炎患者,接受bDMARDs至少3个月。
  • 采用WPI和PainDETECT问卷分别量化伤害可塑性和神经病理性疼痛成分。
  • 以ASDAS和BASDAI作为残留症状指标,CRP作为全身炎症活动指标,进行单变量和多变量回归分析及聚类分析。

主要发现

  • 多变量线性回归显示WPI与ASDAS独立相关(b=0.1,95%CI 0.04-0.17),PD与ASDAS独立相关(b=0.05,95%CI 0.02-0.08)。
  • WPI与BASDAI独立相关(b=0.24,95%CI 0.08-0.39),PD与BASDAI独立相关(b=0.17,95%CI 0.1-0.25)。
  • WPI与BASDAI≥4定义的残留症状显著相关(OR 1.93,95%CI 1.09-4.15),PD亦显著相关(OR 1.32,95%CI 1.04-1.85)。
  • 在CRP正常水平的患者中上述效应同样存在。
  • 聚类分析揭示三种不同的疼痛分布特征和四种特定的感觉症状组合,可区分不同的疼痛亚型。

关键数值与推荐

  • WPI与ASDAS的回归系数b=0.1(95%CI 0.04-0.17),PD与ASDAS的b=0.05(95%CI 0.02-0.08)。
  • WPI与BASDAI的b=0.24(95%CI 0.08-0.39),PD与BASDAI的b=0.17(95%CI 0.1-0.25)。
  • WPI与BASDAI≥4残留症状的OR=1.93(95%CI 1.09-4.15),PD的OR=1.32(95%CI 1.04-1.85)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association of nociplastic (NoP) and neuropathic pain (NP) components with residual symptoms in patients with radiographic axial spondyloarthritis (r-axSpA) receiving biological disease-modifying antirheumatic drugs (bDMARDs). METHODS: 78 patients with r-axSpA from the GErman SPondyloarthritis Inception Cohort receiving a bDMARD for at least 3 months were included in this analysis. The Widespread Pain Index (WPI) and the PainDETECT (PD) questionnaire were used to quantify the NoP and the NP components, respectively. Axial Spondyloarthritis Disease Activity Score (ASDAS) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were used as measures of residual symptoms. C reactive protein (CRP) was used as a measure of systemic inflammatory activity. Univariable and multivariable regression analyses of disease activity were performed. The regions of the WPI score and items of the PD score were used for cluster analyses. RESULTS: Linear multivariable regression analysis showed that WPI and PD were independently associated with ASDAS (b=0.1, 95% CI 0.04 to 0.17, and b=0.05, 95% CI 0.02 to 0.08, respectively) and BASDAI (b=0.24, 95% CI 0.08 to 0.39, and b=0.17, 95% CI 0.1 to 0.25, respectively) in r-axSpA patients receiving stable treatment with bDMARDs. Furthermore, WPI and PD were found to be significantly associated with the presence of relevant residual symptoms as defined by BASDAI ≥4 (OR 1.93, 95% CI 1.09 to 4.15, and OR 1.32, 95% CI 1.04 to 1.85, respectively). The effects were present also in patients with normal level of CRP. Cluster analysis revealed three distinct pain distribution profiles and four specific sensory symptom constellations allowing differentiation of different pain subtypes. CONCLUSION: Both NoP and NP components seem to be associated with residual symptoms in patients with r-axSpA receiving treatment with bDMARDs.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Al Mohamad F, Rios Rodriguez V, Haibel H, et al. Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD Open. 2024. PMID: 38360039. doi:10.1136/rmdopen-2023-004009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。